Avidity Biosciences
RNAM
#1855
Rank
C$15.91 B
Marketcap
C$103.03
Share price
0.00%
Change (1 day)
46.78%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Last known market cap: C$15.91 Billion

As of September 2026 Avidity Biosciences has a market cap of C$15.91 Billion. This makes Avidity Biosciences the world's 1855th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026C$15.91 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$231.19 B 1,352.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$139.52 B 776.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$2.79 B-82.47%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$7.40 B-53.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.39 B-97.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.16 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$15.46 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$5.45 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA